Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bitcoin

Strategy Shares Plunge as Index Snub Sparks Investor Panic

Felix Baarz by Felix Baarz
November 29, 2025
in Bitcoin, Blockchain, Crypto Stocks, S&P 500
0
Strategy Stock
0
SHARES
35
VIEWS
Share on FacebookShare on Twitter

The company formerly known as MicroStrategy is navigating one of the most turbulent periods in its recent market history. Investors received another severe setback when the firm failed to secure inclusion in the prestigious S&P 500 index, raising fundamental questions about its business approach. As share values deteriorate and major institutions face substantial losses, an even greater threat to the stock’s liquidity now looms on the horizon.

Institutional Losses Mount Rapidly

The dramatic price collapse has devastated institutional investment portfolios. California’s public pension fund CalPERS, among the largest in the United States, has been particularly impacted. During the third quarter, the fund established a $144 million position in Strategy shares. Following the recent crash, this investment has dwindled to approximately $80 million, highlighting the extreme volatility and inherent dangers of the company’s leveraged operational framework.

The S&P 500 Rejection

The latest blow came directly from the index committee. Despite Strategy technically meeting standard inclusion criteria—including market capitalization, liquidity, and profitability—the S&P 500 door remained closed. The committee selected SanDisk as the replacement constituent instead.

This decision sends an unambiguous market signal: index guardians continue to avoid incorporating a company with such an aggressive Bitcoin-focused strategy into the world’s premier benchmark index. For investors banking on substantial capital inflows from index funds, this represents a severe disappointment.

Potential Index Exclusion Threatens Further Damage

The situation could deteriorate further. JPMorgan analysts highlight a structural risk hanging over the share price: potential removal from MSCI indices. Critics contend that the company’s overwhelming Bitcoin focus has transformed it from an operational corporation into a specialized investment vehicle.

Should investors sell immediately? Or is it worth buying Strategy?

Should MSCI take action, forced selling by passive funds could reach billions of dollars. Estimates project capital outflows between $2.8 billion and a catastrophic $8.8 billion if additional index providers follow suit. This concern currently weighs heavily on market sentiment.

Fundamental Vulnerability to Crypto Markets

The stock’s fate remains fundamentally tied to cryptocurrency market movements. With approximately 650,000 Bitcoin on its balance sheet, Strategy effectively functions as a leveraged Bitcoin proxy. The recent correction in cryptocurrency values from their peak levels has dragged the share price downward like an anchor.

Current data presents a sobering picture: shares closed at €154.00, trading nearly 61% below their 52-week high. The short-term trend appears equally bleak, with the stock declining over 35% in the past month alone.

Market tension remains palpable. While some analysts still identify potential in the company’s software division, fear of additional forced selling currently dominates trading psychology. Investors now watch technical support levels intently, wondering whether the current price floor will hold or whether the combination of index frustration and cryptocurrency weakness will push valuations into even deeper territory.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from February 7 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Felix Baarz

Felix Baarz

My name is Felix Baarz, and I look back on over fifteen years of experience as a business journalist. I have always been fascinated by the mechanisms and dynamics of global financial markets as well as the complex economic and political interconnections that shape our world. With this passion, I have made a name for myself as an expert on international financial markets and dedicate myself with great commitment to making even the most complex topics understandable and accessible to my readers. My roots lie in Cologne, where I was born and raised. Early on, my curiosity about economic topics and international developments sparked my interest in journalism. After completing my studies, I began my career as a business editor at a respected German trade publication. Here I laid the foundation for my professional career, but my curiosity soon drew me out into the wider world. A turning point in my life was moving to New York, where I lived for six years and gained insight into leading media houses. In this vibrant metropolis, I was able to report firsthand from the heart of the global financial world. From daily developments on Wall Street to major economic policy decisions that make waves worldwide, I had the opportunity to write about central topics that move people and markets alike. This time shaped my perspective and sharpened my view of global interconnections.

Related Posts

Yirendai Stock
AI & Quantum Computing

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
Diginex Stock
Blockchain

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026
S&P 500 Stock
Market Commentary

US Benchmark Index Breaches Key Threshold Amid Tech and Jobs Concerns

February 6, 2026
Next Post
Diginex Stock

Diginex Shares Plunge Amid Overwhelming Selling Pressure

XRP Stock

XRP at a Critical Juncture: Institutional Momentum Meets Technical Resistance

Novo Nordisk Stock

Novo Nordisk's Strategic Pivot: Can a Higher-Dose Wegovy Offset Alzheimer's Setback?

Recommended

C3.ai Stock

Is C3.ai Stock Poised for a Rebound?

2 months ago
MMM stock news

Clarification on Hyperlink and Promotional Fees

2 years ago

XOMA Corporation Expands Portfolio with Acquisition of DSUVIA

2 years ago
Microsoft Stock

A Bold Bet: Peter Thiel’s Hedge Fund Doubles Down on Microsoft

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

ServiceNow Shares Face Market Skepticism Despite Record Performance

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

A New Chapter for First Busey as CrossFirst Merger Finalizes

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Trending

Avanos Medical Stock
Analysis

Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth

by SiterGedge
February 7, 2026
0

Avanos Medical is navigating a critical strategic transformation. The medical device firm is streamlining its operations to...

Guaranty Bancshares Stock

Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion

February 7, 2026
Yirendai Stock

Yirendai Charts a New Course with Tech-Driven Strategy

February 7, 2026
ServiceNow Stock

ServiceNow Shares Face Market Skepticism Despite Record Performance

February 7, 2026
Orthofix Medical Stock

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Avanos Medical’s Strategic Pivot: A Focus on High-Margin Growth
  • Guaranty Bancshares Sees Growth Accelerate Following Texas Expansion
  • Yirendai Charts a New Course with Tech-Driven Strategy

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com